Given the role played by insulin resistance and hyperglycemia in morbidity and mortality, interventions showing potential in enhancing insulin action in the peripheral tissue present opportunities to combat a range of pathologies associated with metabolic syndrome. The gene discussed is INS; the disease is metabolic syndrome.